PAPER
SEARCH RESULTS
331159 RESULTS
PAPER Robin NC, Agoston Z, Biechele TL, James RG, Berndt JD, Moon RT
Simvastatin Promotes Adult Hippocampal Neurogenesis by Enhancing Wnt/β-Catenin Signaling.
Stem Cell Reports. 2014 Jan 14;2(1):9-17. Epub 2013 Dec 26 PubMed: 24511465PAPER Canudas J, Insua D, Sarasa L, González-Martínez A, Suárez ML, Santamarina G, Pesini P, Sarasa M
Neprilysin is poorly expressed in the prefrontal cortex of aged dogs with cognitive dysfunction syndrome.
Int J Alzheimers Dis. 2014;2014:483281. Epub 2014 Jan 6 PubMed: 24511411PAPER Foster DJ, Choi DL, Conn PJ, Rook JM
Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia.
Neuropsychiatr Dis Treat. 2014;10:183-91. Epub 2014 Jan 28 PubMed: 24511233PAPER Ihara M, Taguchi A, Maki T, Washida K, Tomimoto H
A mouse model of chronic cerebral hypoperfusion characterizing features of vascular cognitive impairment.
Methods Mol Biol. 2014;1135:95-102. PubMed: 24510857PAPER Ithapu V, Singh V, Lindner C, Austin BP, Hinrichs C, Carlsson CM, Bendlin BB, Johnson SC
Extracting and summarizing white matter hyperintensities using supervised segmentation methods in Alzheimer's disease risk and aging studies.
Hum Brain Mapp. 2014 Aug;35(8):4219-35. Epub 2014 Feb 7 PubMed: 24510744PAPER Mahoney CJ, Ridgway GR, Malone IB, Downey LE, Beck J, Kinnunen KM, Schmitz N, Golden HL, Rohrer JD, Schott JM, Rossor MN, Ourselin S, Mead S, Fox NC, Warren JD
Profiles of white matter tract pathology in frontotemporal dementia.
Hum Brain Mapp. 2014 Aug;35(8):4163-79. Epub 2014 Feb 7 PubMed: 24510641PAPER
Upcoming meetings related to Alzheimer's disease.
J Alzheimers Dis. 2014 Jan 1;39(3) PubMed: 24509628PAPER Mizoi M, Yoshida M, Saiki R, Waragai M, Uemura K, Akatsu H, Kashiwagi K, Igarashi K
Distinction between mild cognitive impairment and Alzheimer's disease by CSF amyloid β40 and β42, and protein-conjugated acrolein.
Clin Chim Acta. 2014 Mar 20;430:150-5. Epub 2014 Feb 6 PubMed: 24508996PAPER Bennett DA, Yu L, De Jager PL
Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.
Biochem Pharmacol. 2014 Apr 15;88(4):617-30. Epub 2014 Feb 6 PubMed: 24508835PAPER Thiratmatrakul S, Yenjai C, Waiwut P, Vajragupta O, Reubroycharoen P, Tohda M, Boonyarat C
Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Eur J Med Chem. 2014 Mar 21;75:21-30. Epub 2014 Jan 22 PubMed: 24508831PAPER Yamamoto N, Tanida M, Ono Y, Kasahara R, Fujii Y, Ohora K, Suzuki K, Sobue K
Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes.
Biochem Biophys Res Commun. 2014 Feb 28;445(1):214-7. Epub 2014 Feb 6 PubMed: 24508800PAPER Kober DL, Wanhainen KM, Johnson BM, Randolph DT, Holtzman MJ, Brett TJ
Preparation, crystallization, and preliminary crystallographic analysis of wild-type and mutant human TREM-2 ectodomains linked to neurodegenerative and inflammatory diseases.
Protein Expr Purif. 2014 Apr;96:32-8. Epub 2014 Feb 7 PubMed: 24508568PAPER Guo Y, Shi S, Tang M, Liang D, Xu W, Wang L, Wang Z, Qiao Z
The suppressive effects of gx-50 on Aβ-induced chemotactic migration of microglia.
Int Immunopharmacol. 2014 Apr;19(2):283-9. Epub 2014 Feb 5 PubMed: 24508536PAPER Stukas S, Robert J, Wellington CL
High-density lipoproteins and cerebrovascular integrity in Alzheimer's disease.
Cell Metab. 2014 Apr 1;19(4):574-91. Epub 2014 Feb 6 PubMed: 24508505Current Filters
No filters selected